Colpofix from Uriach, with an exclusive application mechanism, awarded for its innovation

January 11, 2021

Colpofix is a product of Uriah indicated for the maintenance of the transformation zone of the cervico-vaginal mucosa, as well as alterations due to the human papillomavirus (HPV), thanks to the control of the physiological conditions of the transformation zone of the cervix. It has been one of the winners in the category 'Excellence in Pharma: Finished Products' in the 17th edition of the CPhI Awards 2020.

Colpofix is ​​a nebulizable vaginal gel that, by means of an exclusive application mechanism and thanks to its formulation, allows the product to be dispensed directly onto the cervix, favoring a uniform and effective distribution of the preparation.

You may be interested in continuing reading ...

Translate »